Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia
Chenglin Wu(Shanghai Institute of Materia Medica), Hong Liu(Chinese Academy of Sciences)
Cited by 26
Related Papers
Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells
|The Journal of Cell Biology|2004|218
Downregulation of BAG‑1 in T47D cells promotes resistance to tamoxifen via activation of the PI3K/Akt/mTOR signaling pathway
|Oncology Reports|2019|7